Moolec Science (MLEC) Receivables - Net (2022 - 2025)
Moolec Science (MLEC) reported Receivables - Net of $6.1 million for Q2 2025, down 97.09% on a YoY basis from $209.0 million in Q2 2024, and up 215.34% sequentially from $1.9 million in Q4 2024.
Moolec Science (MLEC) Receivables - Net (2022 - 2025) Analysis & Trends
Moolec Science (MLEC) has 4 years of Receivables - Net data on file, last reported at $6.1 million in Q2 2025.
- For the quarter ending Q2 2025, Receivables - Net fell 97.09% year-over-year to $6.1 million; the trailing twelve-month figure through Jun 2025 stood at $6.1 million (down 97.09% YoY), and the FY2025 full-year result was $6.1 million, down 97.09% from the prior year.
- Receivables - Net advanced to $6.1 million in Q2 2025, from $1.9 million in the prior quarter.
- In the past five years, Receivables - Net ranged from a high of $209.0 million in Q2 2024 to a low of $2061.0 in Q2 2022.
- A 4-year average of $22.0 million and a median of $525642.5 in 2023 frame the typical range for Receivables - Net.
- Across the five-year window, Receivables - Net surged 57781.18% in 2024 and sank 97.09% in 2025, its largest moves.
- Tracing MLEC's Receivables - Net over 4 years: stood at $2061.0 in 2022, then surged by 13720.91% to $284849.0 in 2023, then jumped by 577.48% to $1.9 million in 2024, then jumped by 215.34% to $6.1 million in 2025.
- Business Quant data shows MLEC's Receivables - Net at $6.1 million in Q2 2025, $1.9 million in Q4 2024, and $553542.0 in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,102.16 Bn | 67,101.87 Bn | - |
| 2 | Nanobiotix | 1,913.50 Bn | 1,913.44 Bn | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - |
| 4 | BeOne Medicines | 473.74 Bn | 468.95 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.07 Bn | 114.82 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.00 Bn | 61.24 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.34 Bn | 62.34 Bn | - |
| 8 | Argenx Se | 55.96 Bn | 50.77 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.49 Bn | 34.48 Bn | 959.66 Mn |
| 10 | Moolec Science | 5.35 Bn | 5.35 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 6.09 Mn |
| Jun 30, 2025 | 6.09 Mn |
| Dec 31, 2024 | 1.93 Mn |
| Dec 31, 2024 | 1.93 Mn |
| Sep 30, 2024 | 553,542.00 |
| Sep 30, 2024 | 553,542.00 |
| Jun 30, 2024 | 209.01 Mn |
| Jun 30, 2024 | 209.01 Mn |
| Mar 31, 2024 | 548,336.00 |
| Mar 31, 2024 | 548,336.00 |
| Dec 31, 2023 | 284,849.00 |
| Dec 31, 2023 | 284,849.00 |
| Sep 30, 2023 | 502,949.00 |
| Sep 30, 2023 | 502,949.00 |
| Jun 30, 2023 | 361,097.00 |
| Jun 30, 2023 | 361,097.00 |
| Mar 31, 2023 | 316,972.00 |
| Mar 31, 2023 | 316,972.00 |
| Jun 30, 2022 | 2,061.00 |
| Jun 30, 2022 | 2,061.00 |